Cross-Sectional Relations of Lipid Concentrations to Left Ventricular Structural Attributes
March 13th, 2010 Posted by: admin
Publication year: 2010
Source: The American Journal of Cardiology, In Press, Corrected Proof, Available online 11 March 2010
Raghava S., Velagaleti , Michael J., Pencina , Ramachandran S., Vasan , Emelia J., Benjamin , Joseph M., Massaro , …
Although previous investigations reported on the associations of lipid concentrations with left ventricular remodeling in specific subpopulations, few data exist on these associations in a community-based sample of subjects without cardiovascular disease. In this study, 3,554 Framingham Heart Study participants (mean age 47 years, 53% women) without preexisting clinical cardiovascular disease were examined, and no meaningful associations of high-density lipoprotein cholesterol or non–high-density lipoprotein cholesterol with echocardiographic indexes of left ventricular structure were observed. In conclusion, these data do not support an independent association between lipid concentrations and left ventricular structure.
Similar Posts:
- Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical Trials
- Relation of Serum Leptin With Cardiac Mass and Left Atrial Dimension in Individuals >70 Years of Age
- Distribution of Traditional and Novel Risk Factors and Their Relation to Subsequent Cardiovascular Events in Patients With Acute Coronary Syndromes (from the PROVE IT-TIMI 22 Trial)
- Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study.
- Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
- Ability of Physical Activity to Predict Cardiovascular Disease Beyond Commonly Evaluated Cardiometabolic Risk Factors
- Novel Targets that Affect High-Density Lipoprotein Metabolism: The Next Frontier
- Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens
- Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup’ik Eskimos.
- Cardiovascular risk reduction: What do recent trials with rosuvastatin tell us?